ID   DGUOK_HUMAN             Reviewed;         277 AA.
AC   Q16854; P78532; Q16759; Q4ZG09; Q7L1W9; Q96BC1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   12-APR-2017, entry version 169.
DE   RecName: Full=Deoxyguanosine kinase, mitochondrial;
DE            Short=dGK;
DE            EC=2.7.1.113;
DE   Flags: Precursor;
GN   Name=DGUOK; Synonyms=DGK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8692979; DOI=10.1073/pnas.93.14.7258;
RA   Johansson M., Karlsson A.;
RT   "Cloning and expression of human deoxyguanosine kinase cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7258-7262(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6).
RC   TISSUE=B-cell, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 18-277, CATALYTIC ACTIVITY, FUNCTION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8706825; DOI=10.1016/0014-5793(96)00623-0;
RA   Wang L., Hellman U., Eriksson S.;
RT   "Cloning and expression of human mitochondrial deoxyguanosine kinase
RT   cDNA.";
RL   FEBS Lett. 390:39-43(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-47.
RA   Stegmann A.P.A., Mitchell B.S.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION.
RX   PubMed=11687801; DOI=10.1038/ng751;
RA   Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., Elpeleg O.;
RT   "Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion
RT   myopathy.";
RL   Nat. Genet. 29:342-344(2001).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   FUNCTION, CHARACTERIZATION OF VARIANT NCPH SER-46, AND
RP   CHARACTERIZATION OF VARIANT ARG-266.
RX   PubMed=17073823; DOI=10.1042/BJ20060705;
RA   Mousson de Camaret B., Taanman J.W., Padet S., Chassagne M.,
RA   Mayencon M., Clerc-Renaud P., Mandon G., Zabot M.T., Lachaux A.,
RA   Bozon D.;
RT   "Kinetic properties of mutant deoxyguanosine kinase in a case of
RT   reversible hepatic mtDNA depletion.";
RL   Biochem. J. 402:377-385(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 37-277 IN COMPLEX WITH
RP   DEOXYADENOSINE 5'-TRIPHOSPHATE, AND SUBUNIT.
RX   PubMed=11427893; DOI=10.1038/89661;
RA   Johansson K., Ramaswamy S., Ljungcrantz C., Knecht W., Piskur J.,
RA   Munch-Petersen B., Eriksson S., Eklund H.;
RT   "Structural basis for substrate specificities of cellular
RT   deoxyribonucleoside kinases.";
RL   Nat. Struct. Biol. 8:616-620(2001).
RN   [11]
RP   VARIANTS MTDPS3 LYS-142 AND LYS-227.
RX   PubMed=12205643; DOI=10.1002/ana.10284;
RA   Salviati L., Sacconi S., Mancuso M., Otaegui D., Camano P., Marina A.,
RA   Rabinowitz S., Shiffman R., Thompson K., Wilson C.M., Feigenbaum A.,
RA   Naini A.B., Hirano M., Bonilla E., DiMauro S., Vu T.H.;
RT   "Mitochondrial DNA depletion and dGK gene mutations.";
RL   Ann. Neurol. 52:311-317(2002).
RN   [12]
RP   VARIANT MTDPS3 SER-250, AND CHARACTERIZATION OF VARIANT MTDPS3
RP   SER-250.
RX   PubMed=15639197; DOI=10.1016/j.ymgme.2004.09.005;
RA   Wang L., Limongelli A., Vila M.R., Carrara F., Zeviani M.,
RA   Eriksson S.;
RT   "Molecular insight into mitochondrial DNA depletion syndrome in two
RT   patients with novel mutations in the deoxyguanosine kinase and
RT   thymidine kinase 2 genes.";
RL   Mol. Genet. Metab. 84:75-82(2005).
RN   [13]
RP   INVOLVEMENT IN PEOB4, VARIANTS PEOB4 LYS-44 AND LYS-154,
RP   CHARACTERIZATION OF VARIANTS PEOB4 LYS-44 AND LYS-154, VARIANT
RP   ARG-170, AND FUNCTION.
RX   PubMed=23043144; DOI=10.1093/brain/aws258;
RA   Ronchi D., Garone C., Bordoni A., Gutierrez Rios P., Calvo S.E.,
RA   Ripolone M., Ranieri M., Rizzuti M., Villa L., Magri F., Corti S.,
RA   Bresolin N., Mootha V.K., Moggio M., DiMauro S., Comi G.P.,
RA   Sciacco M.;
RT   "Next-generation sequencing reveals DGUOK mutations in adult patients
RT   with mitochondrial DNA multiple deletions.";
RL   Brain 135:3404-3415(2012).
RN   [14]
RP   INVOLVEMENT IN NCPH, AND VARIANT NCPH SER-46.
RX   PubMed=26874653; DOI=10.1002/hep.28499;
RA   Vilarinho S., Sari S., Yilmaz G., Stiegler A.L., Boggon T.J., Jain D.,
RA   Akyol G., Dalgic B., Guenel M., Lifton R.P.;
RT   "Recurrent recessive mutation in deoxyguanosine kinase causes
RT   idiopathic noncirrhotic portal hypertension.";
RL   Hepatology 63:1977-1986(2016).
CC   -!- FUNCTION: Phosphorylates deoxyguanosine and deoxyadenosine in the
CC       mitochondrial matrix, with the highest efficiency for
CC       deoxyguanosine. In non-replicating cells, where cytosolic dNTP
CC       synthesis is down-regulated, mtDNA synthesis depends solely on
CC       DGUOK and TK2. Phosphorylates certain nucleoside analogs. Widely
CC       used as target of antiviral and chemotherapeutic agents.
CC       {ECO:0000269|PubMed:11687801, ECO:0000269|PubMed:17073823,
CC       ECO:0000269|PubMed:23043144, ECO:0000269|PubMed:8706825}.
CC   -!- CATALYTIC ACTIVITY: ATP + deoxyguanosine = ADP + dGMP.
CC       {ECO:0000269|PubMed:8706825}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11427893}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q16854-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16854-2; Sequence=VSP_003025;
CC       Name=3;
CC         IsoId=Q16854-3; Sequence=VSP_003024;
CC       Name=4;
CC         IsoId=Q16854-4; Sequence=VSP_003024, VSP_003025;
CC       Name=5;
CC         IsoId=Q16854-5; Sequence=VSP_003026, VSP_003024;
CC       Name=6;
CC         IsoId=Q16854-6; Sequence=VSP_056026, VSP_056027;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest expression in muscle,
CC       brain, liver and lymphoid tissues. {ECO:0000269|PubMed:8706825}.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 3 (MTDPS3)
CC       [MIM:251880]: A disorder due to mitochondrial dysfunction
CC       characterized by onset in infancy of progressive liver failure,
CC       hypoglycemia, increased lactate in body fluids, and neurologic
CC       abnormalities including hypotonia, encephalopathy, peripheral
CC       neuropathy. Affected tissues show both decreased activity of the
CC       mtDNA-encoded respiratory chain complexes and mtDNA depletion.
CC       {ECO:0000269|PubMed:12205643, ECO:0000269|PubMed:15639197}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Portal hypertension, non-cirrhotic (NCPH) [MIM:617068]:
CC       An autosomal recessive disorder characterized by portal
CC       hypertension associated with hepatosplenomegaly, in absence of
CC       cirrhosis, extrahepatic diseases, and splanchnic venous
CC       thrombosis. Portal hypertension is defined by a portal venous
CC       system pressure that is at least 5 mm Hg higher than the pressure
CC       in the inferior vena cava. High pressure in the portal venous
CC       system leads to shunting of blood through vessels that are poorly
CC       suited to carrying large blood volumes, resulting in collateral
CC       circulation and splenomegaly. NCPH patients show normal liver
CC       function. {ECO:0000269|PubMed:17073823,
CC       ECO:0000269|PubMed:26874653}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal recessive 4 (PEOB4) [MIM:617070]: A form
CC       of progressive external ophthalmoplegia, a mitochondrial myopathy
CC       characterized by progressive paralysis of the levator palpebrae,
CC       orbicularis oculi, and extraocular muscles. PEOB4 patients
CC       manifest clinically variable features including mitochondrial
CC       myopathy with or without progressive external ophthalmoplegia,
CC       recurrent rhabdomyolysis, and adult-onset lower motor neuron
CC       syndrome with mild cognitive impairment.
CC       {ECO:0000269|PubMed:23043144}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DCK/DGK family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U41668; AAC50624.1; -; mRNA.
DR   EMBL; AC073046; AAX88910.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99704.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99707.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99709.1; -; Genomic_DNA.
DR   EMBL; BC015757; AAH15757.1; -; mRNA.
DR   EMBL; BC024019; AAH24019.1; -; mRNA.
DR   EMBL; X97386; CAA66054.1; -; mRNA.
DR   EMBL; U81499; AAB39858.1; -; Genomic_DNA.
DR   CCDS; CCDS1931.1; -. [Q16854-1]
DR   CCDS; CCDS1932.1; -. [Q16854-2]
DR   PIR; JC6142; JC6142.
DR   PIR; S71315; S71315.
DR   RefSeq; NP_001305788.1; NM_001318859.1.
DR   RefSeq; NP_001305789.1; NM_001318860.1.
DR   RefSeq; NP_001305790.1; NM_001318861.1.
DR   RefSeq; NP_001305791.1; NM_001318862.1.
DR   RefSeq; NP_001305792.1; NM_001318863.1.
DR   RefSeq; NP_550438.1; NM_080916.2. [Q16854-1]
DR   RefSeq; NP_550440.1; NM_080918.2. [Q16854-2]
DR   UniGene; Hs.469022; -.
DR   PDB; 2OCP; X-ray; 2.80 A; A/B/C/D/E/F/G/H=37-277.
DR   PDBsum; 2OCP; -.
DR   ProteinModelPortal; Q16854; -.
DR   SMR; Q16854; -.
DR   BioGrid; 108062; 71.
DR   IntAct; Q16854; 1.
DR   STRING; 9606.ENSP00000264093; -.
DR   BindingDB; Q16854; -.
DR   ChEMBL; CHEMBL5997; -.
DR   DrugBank; DB01280; Nelarabine.
DR   iPTMnet; Q16854; -.
DR   PhosphoSitePlus; Q16854; -.
DR   BioMuta; DGUOK; -.
DR   DMDM; 23503050; -.
DR   EPD; Q16854; -.
DR   MaxQB; Q16854; -.
DR   PaxDb; Q16854; -.
DR   PeptideAtlas; Q16854; -.
DR   PRIDE; Q16854; -.
DR   DNASU; 1716; -.
DR   Ensembl; ENST00000264093; ENSP00000264093; ENSG00000114956. [Q16854-1]
DR   Ensembl; ENST00000348222; ENSP00000306964; ENSG00000114956. [Q16854-2]
DR   Ensembl; ENST00000418996; ENSP00000408209; ENSG00000114956. [Q16854-6]
DR   Ensembl; ENST00000629438; ENSP00000487122; ENSG00000114956. [Q16854-6]
DR   GeneID; 1716; -.
DR   KEGG; hsa:1716; -.
DR   UCSC; uc002sjx.3; human. [Q16854-1]
DR   CTD; 1716; -.
DR   DisGeNET; 1716; -.
DR   GeneCards; DGUOK; -.
DR   GeneReviews; DGUOK; -.
DR   HGNC; HGNC:2858; DGUOK.
DR   HPA; HPA034766; -.
DR   HPA; HPA057246; -.
DR   MalaCards; DGUOK; -.
DR   MIM; 251880; phenotype.
DR   MIM; 601465; gene.
DR   MIM; 617068; phenotype.
DR   MIM; 617070; phenotype.
DR   neXtProt; NX_Q16854; -.
DR   OpenTargets; ENSG00000114956; -.
DR   Orphanet; 329314; Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency.
DR   Orphanet; 279934; Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency.
DR   PharmGKB; PA27319; -.
DR   eggNOG; KOG4235; Eukaryota.
DR   eggNOG; COG1428; LUCA.
DR   GeneTree; ENSGT00510000046588; -.
DR   HOGENOM; HOG000290165; -.
DR   HOVERGEN; HBG006216; -.
DR   InParanoid; Q16854; -.
DR   KO; K00904; -.
DR   OMA; HGQHEAW; -.
DR   OrthoDB; EOG091G0G7H; -.
DR   PhylomeDB; Q16854; -.
DR   TreeFam; TF324413; -.
DR   BioCyc; MetaCyc:HS03819-MONOMER; -.
DR   BRENDA; 2.7.1.113; 2681.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   SABIO-RK; Q16854; -.
DR   ChiTaRS; DGUOK; human.
DR   EvolutionaryTrace; Q16854; -.
DR   GeneWiki; DGUOK; -.
DR   GenomeRNAi; 1716; -.
DR   PRO; PR:Q16854; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000114956; -.
DR   CleanEx; HS_DGUOK; -.
DR   ExpressionAtlas; Q16854; baseline and differential.
DR   Genevisible; Q16854; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004138; F:deoxyguanosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0019206; F:nucleoside kinase activity; EXP:Reactome.
DR   GO; GO:0046070; P:dGTP metabolic process; IEA:Ensembl.
DR   GO; GO:0008617; P:guanosine metabolic process; TAS:ProtInc.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0046122; P:purine deoxyribonucleoside metabolic process; IDA:UniProtKB.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   InterPro; IPR002624; DCK/DGK.
DR   InterPro; IPR031314; DNK_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01712; dNK; 1.
DR   PIRSF; PIRSF000705; DNK; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Disease mutation; Kinase; Mitochondrion;
KW   Neuropathy; Nucleotide-binding; Progressive external ophthalmoplegia;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     39       Mitochondrion. {ECO:0000255}.
FT   CHAIN        40    277       Deoxyguanosine kinase, mitochondrial.
FT                                /FTId=PRO_0000016840.
FT   NP_BIND      45     53       ATP.
FT   NP_BIND     206    208       ATP.
FT   ACT_SITE    141    141       Proton acceptor. {ECO:0000255}.
FT   BINDING      70     70       Substrate. {ECO:0000250}.
FT   BINDING     100    100       Substrate.
FT   BINDING     111    111       Substrate.
FT   BINDING     118    118       Substrate.
FT   BINDING     142    142       Substrate.
FT   BINDING     147    147       Substrate. {ECO:0000250}.
FT   BINDING     211    211       Substrate.
FT   MOD_RES     275    275       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ      47     47       I -> IGNILKQIRGRAPIQET (in isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_003026.
FT   VAR_SEQ      48     89       AVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACT
FT                                A -> GLHCPKSWKLAGYDVPGASTMVLHIPDIFLFEPPES
FT                                TAGALP (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056026.
FT   VAR_SEQ      48     85       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_003024.
FT   VAR_SEQ      90    277       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056027.
FT   VAR_SEQ     149    236       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_003025.
FT   VARIANT      44     44       E -> K (in PEOB4; decreased protein
FT                                levels; dbSNP:rs762550967).
FT                                {ECO:0000269|PubMed:23043144}.
FT                                /FTId=VAR_076979.
FT   VARIANT      46     46       N -> S (in NCPH; impairs adenosine
FT                                triphosphate binding; reduction of
FT                                activity; dbSNP:rs763615602).
FT                                {ECO:0000269|PubMed:17073823,
FT                                ECO:0000269|PubMed:26874653}.
FT                                /FTId=VAR_076980.
FT   VARIANT     142    142       R -> K (in MTDPS3; dbSNP:rs104893631).
FT                                {ECO:0000269|PubMed:12205643}.
FT                                /FTId=VAR_019417.
FT   VARIANT     154    154       N -> K (in PEOB4; decreased protein
FT                                levels; dbSNP:rs144181978).
FT                                {ECO:0000269|PubMed:23043144}.
FT                                /FTId=VAR_076981.
FT   VARIANT     170    170       Q -> R (unknown pathological
FT                                significance; dbSNP:rs74874677).
FT                                {ECO:0000269|PubMed:23043144}.
FT                                /FTId=VAR_076982.
FT   VARIANT     227    227       E -> K (in MTDPS3; dbSNP:rs104893632).
FT                                {ECO:0000269|PubMed:12205643}.
FT                                /FTId=VAR_019418.
FT   VARIANT     250    250       L -> S (in MTDPS3; significant reduction
FT                                of activity; dbSNP:rs749464475).
FT                                {ECO:0000269|PubMed:15639197}.
FT                                /FTId=VAR_023789.
FT   VARIANT     266    266       L -> R (reduction of activity).
FT                                {ECO:0000269|PubMed:17073823}.
FT                                /FTId=VAR_076983.
FT   CONFLICT     83     83       T -> N (in Ref. 1; AAC50624).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       G -> D (in Ref. 5; CAA66054).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       K -> E (in Ref. 5; CAA66054).
FT                                {ECO:0000305}.
FT   STRAND       39     45       {ECO:0000244|PDB:2OCP}.
FT   HELIX        51     61       {ECO:0000244|PDB:2OCP}.
FT   STRAND       65     68       {ECO:0000244|PDB:2OCP}.
FT   HELIX        72     74       {ECO:0000244|PDB:2OCP}.
FT   HELIX        95    101       {ECO:0000244|PDB:2OCP}.
FT   HELIX       103    123       {ECO:0000244|PDB:2OCP}.
FT   HELIX       128    131       {ECO:0000244|PDB:2OCP}.
FT   STRAND      137    142       {ECO:0000244|PDB:2OCP}.
FT   HELIX       144    149       {ECO:0000244|PDB:2OCP}.
FT   HELIX       151    157       {ECO:0000244|PDB:2OCP}.
FT   HELIX       163    179       {ECO:0000244|PDB:2OCP}.
FT   HELIX       181    184       {ECO:0000244|PDB:2OCP}.
FT   STRAND      188    193       {ECO:0000244|PDB:2OCP}.
FT   HELIX       196    205       {ECO:0000244|PDB:2OCP}.
FT   TURN        209    213       {ECO:0000244|PDB:2OCP}.
FT   HELIX       216    230       {ECO:0000244|PDB:2OCP}.
FT   HELIX       242    244       {ECO:0000244|PDB:2OCP}.
FT   STRAND      247    251       {ECO:0000244|PDB:2OCP}.
FT   TURN        256    258       {ECO:0000244|PDB:2OCP}.
FT   HELIX       260    275       {ECO:0000244|PDB:2OCP}.
SQ   SEQUENCE   277 AA;  32056 MW;  53E4514BFC2CB5E5 CRC64;
     MAAGRLFLSR LRAPFSSMAK SPLEGVSSSR GLHAGRGPRR LSIEGNIAVG KSTFVKLLTK
     TYPEWHVATE PVATWQNIQA AGTQKACTAQ SLGNLLDMMY REPARWSYTF QTFSFLSRLK
     VQLEPFPEKL LQARKPVQIF ERSVYSDRYI FAKNLFENGS LSDIEWHIYQ DWHSFLLWEF
     ASRITLHGFI YLQASPQVCL KRLYQRAREE EKGIELAYLE QLHGQHEAWL IHKTTKLHFE
     ALMNIPVLVL DVNDDFSEEV TKQEDLMREV NTFVKNL
//
